Jefferies Financial Group Inc. bought a new position in shares of Constellium SE (NYSE:CSTM - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 232,166 shares of the industrial products company's stock, valued at approximately $2,384,000. Jefferies Financial Group Inc. owned 0.16% of Constellium as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Victory Capital Management Inc. grew its stake in Constellium by 15.1% in the fourth quarter. Victory Capital Management Inc. now owns 947,430 shares of the industrial products company's stock valued at $9,730,000 after purchasing an additional 124,140 shares in the last quarter. State of Alaska Department of Revenue purchased a new position in Constellium in the fourth quarter valued at about $1,386,000. Barclays PLC grew its stake in Constellium by 476.1% in the third quarter. Barclays PLC now owns 336,569 shares of the industrial products company's stock valued at $5,473,000 after purchasing an additional 278,149 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Constellium during the 4th quarter worth about $775,000. Finally, SG Americas Securities LLC boosted its stake in shares of Constellium by 41.7% during the 4th quarter. SG Americas Securities LLC now owns 59,521 shares of the industrial products company's stock worth $611,000 after acquiring an additional 17,515 shares in the last quarter. 92.59% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft upgraded Constellium from a "hold" rating to a "buy" rating and set a $15.00 price target for the company in a research note on Tuesday, February 25th.
Read Our Latest Analysis on CSTM
Constellium Stock Down 2.5%
Shares of CSTM traded down $0.31 during trading hours on Friday, hitting $11.78. 2,127,569 shares of the company were exchanged, compared to its average volume of 1,433,375. The company has a market cap of $1.68 billion, a PE ratio of 36.80 and a beta of 1.65. The firm's 50 day moving average is $10.18 and its 200-day moving average is $10.63. Constellium SE has a 52 week low of $7.33 and a 52 week high of $22.00. The company has a debt-to-equity ratio of 1.93, a quick ratio of 0.52 and a current ratio of 1.28.
Constellium (NYSE:CSTM - Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The industrial products company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.19. The business had revenue of $1.98 billion during the quarter, compared to analysts' expectations of $1.88 billion. Constellium had a return on equity of 4.83% and a net margin of 0.67%. The firm's revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.11 EPS. On average, equities research analysts forecast that Constellium SE will post 1.1 EPS for the current fiscal year.
About Constellium
(
Free Report)
Constellium SE, together with its subsidiaries, engages in the design, manufacture, and sale of rolled and extruded aluminum products for the packaging, aerospace, automotive, defense, and other transportation and industry end-markets. The company operates through three segments: Packaging & Automotive Rolled Products, Aerospace & Transportation, and Automotive Structures & Industry.
Featured Stories

Before you consider Constellium, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Constellium wasn't on the list.
While Constellium currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.